Shineco (SISI) announced that InfiniClone, Shineco’s majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market expansion strategy as it has reached a strategic distribution agreement with Total World Marketing, TWM, pursuant to which TWM will be responsible for the promotion and sale of InfiniClone’s molecular detection kits and InfiniClone’s Purelix series health products in the Southeast Asian market. Shineco believes that this marks a key step in its globalization strategy to develop robust market positioning in the healthcare products and services sector.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI: